We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Chromatin Plasticity Characterizes the Embryonic Stem Cell Nucleus

By LabMedica International staff writers
Posted on 02 Aug 2012
A recent paper presented new insights into the mechanisms that control chromatin plasticity in human embryonic stem cells and that allow these cells to differentiate in to many different types of tissue.

Investigators at the Hebrew University of Jerusalem (Israel) employed molecular, microscopic, and genomic approaches to compare the nature of chromatin (DNA, RNA, and protein) in embryonic stem cells (ESCs) to that found in mature, differentiated cells.

They reported in the June 19, 2012, issue of the journal Nature Communications that the use of epigenetic drugs and mutant ESCs lacking various chromatin proteins revealed that histone acetylation, G9a-mediated histone H3 lysine 9 (H3K9) methylation, and lamin A expression, all affected chromatin protein dynamics. More...


Histone acetylation controlled, almost exclusively, euchromatin protein dynamics. Euchromatin comprises the most active portion of the genome within the cell nucleus. It is a lightly packed form of chromatin that is rich in gene concentration, and is often under active transcription.

Lamin A expression regulates heterochromatin protein dynamics. Heterochromatin is tightly coiled chromosomal material that stains deeply during interphase and is believed to be genetically inactive. In differentiated cells, lamin A binds compacted domains of chromatin and anchors them to the cell’s nuclear envelope. Lamin A was not found in ESCs, which seems to generate a more dynamic chromatin state in the ESC nucleus.

G9a, the histone-lysine N-methyltransferase also known as H3 lysine-9 specific 3, regulates both euchromatin and heterochromatin protein dynamics.

In contrast, the investigators found that DNA methylation and nucleosome repeat length had little or no effect on chromatin-binding protein dynamics in ESCs. Altered chromatin dynamics associated with perturbed ESC differentiation.

“If we can apply this new understanding about the mechanisms that give embryonic stem cells their plasticity, then we can increase or decrease the dynamics of the proteins that bind DNA and thereby increase or decrease the cells’ differentiation potential,” said senior author Dr. Eran Meshorer, professor of genetics at the Hebrew University of Jerusalem. “This could expedite the use of embryonic stem cells in cell therapy and regenerative medicine, by enabling the creation of cells in the laboratory which could be implanted in humans to cure diseases characterized by cell death, such as Alzheimer's, Parkinson's, diabetes, and other degenerative diseases.”

Related Links:

Hebrew University of Jerusalem




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.